KSD-101

· Kousai Bio Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for KSD-101, covering 2024-05-02 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological Malignancies [Phase 1]

See pricing